What is changing in the rules, what it means for your product, your municipality or your project, and who here handles it. In English and Portuguese.
Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.
Ingredient: Acetophenone
Date of publication: 10 November 2025
The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Acetophenone when present as a Natural Complex Substance, following potential classification as a reproductive toxicant under the CLP Regulation.
Topic: Draft 24th to CLP Regulation
Date of publication: 27 November 2025
The European Commission (EC) notified the World Trade Organization's (WTO) Technical Barriers to Trade (TBT) Committee about the 24th Adaptation to Technical and Scientific Progress (ATP) to Regulation (EC) 1272/2008, also known as CLP Regulation. This update amends 48 substances or substance groups, potentially impacting a total of 14 ingredients which can be used in cosmetics.
Topic: Cosmetic ingredients restrictions UK
Date of publication: 31 October 2025
The United Kingdom notified the World Trade Organization (WTO) of a draft regulation, proposing amendments to the ingredient lists in UK Regulation. This update will restrict the threshold for labelling requirements for Formaldehyde releasing substances and prohibit the use of 4-MBC and 16 CMR ingredients.
Topic: Cosmetic ingredients restrictions UK
Date of publication: 27 November 2025
The United Kingdom notified the World Trade Organization (WTO) of a draft regulation, proposing amendments to the ingredient lists in UK Regulation. This update will restrict the use of Hexyl Salicylate and prohibit the use of 13 CMR substances.
Ingredient: Sodium chloride
Date of publication: 27 November 2025
Sweden submitted to ECHA its intention of classify Sodium Chloride as Carc. 2, Muta. 2 and Repr. 1B .
Ingredient: Melaleuca Alternifolia Leaf Oil
Date of publication: 19 November 2025
The Scientific Committee on Consumer Safety (SCCS) has issued its final opinion establishing safe use concentration limits for Tea Tree Oil in cosmetic products, allowing its continued use as an anti-seborrheic and anti-microbial agent despite pending CMR 1B classification under CLP Regulation.
Ingredient: Thiomersal and Phenylmercuric salts
Date of publication: 19 November 2025
The Scientific Committee on Consumer Safety (SCCS) has issued a preliminary opinion concluding that Thiomersal and Phenylmercuric salts are not safe as preservatives at current concentrations permitted in cosmetic products. The deadline for comments is 21st of January 2026.
Ingredient: Basic Blue 99
Date of publication: 19 November 2025
The Scientific Committee on Consumer Safety (SCCS) has concluded that Basic Blue 99 (C059) is not safe for use in non-oxidative hair dye formulations at 1% due to genotoxicity concerns. The deadline for comments is 21st of January 2026.
Ingredient: Butylated Hydroxyanisole
Date of publication: 19 November 2025
The Scientific Committee on Consumer Safety (SCCS) has issued a preliminary opinion concluding that the use of BHA in dermal leave-on and rinse-off products up to a concentration of 0.07% is safe. The deadline for comments is 21st of January 2026.
Ingredient: Cannabidiol
Date of publication: 19 November 2025
The Scientific Committee on Consumer Safety (SCCS) published a preliminary opinion on the safety of Cannabidiol (CBD) in cosmetic products, proposing concentration limits for its use. The deadline for comments is 21st of January 2026.
Ingredient: CYCLAMEN ALDEHYDE
Date of publication: 8 June 2026
The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Cyclamen Aldehyde, following potential classification as a reproductive toxicant under the CLP Regulation.
Topic: OMNIBUS ACT IX - COSMETICS REGULATION
Date of publication: 28 July 2026
The European Commission notified the WTO about the draft Omnibus Act IX, proposing amendments to Annexes II, III, and V of the EU Cosmetics Regulation.
Topic: NEW RESTRICTIONS ON COSMETIC INGREDIENTS
Date of publication: 13 January 2026
The European Commission published Commission Regulation (EU) 2026/78, which brings new restrictions on several cosmetic ingredients that were classified as Carcinogenic, Mutagenic or Toxic for Reproduction (CMR).
Ingredient: TALC
Date of publication: January 2026
The United Kingdom (UK) Health and Safety Executive (HSE) has published a technical report concluding that Talc does not warrant carcinogenicity classification, diverging from ECHA's Risk Assessment Committee (RAC) opinion supporting Category 1B classification.
Four EUDAMED modules have been mandatory since 28 May 2026. Devices already on the market have until 27 November 2026. Who registers what, and what changed in Portugal.
From 25 February 2027, notified bodies under the MDR and IVDR must quote on defined information, keep to maximum timelines and publish their performance. What it changes for manufacturers.
Whether software is a medical device depends on what you say it is for, not on the code. The qualification test under the MDR and IVDR, updated for 2025 guidance.
Clinical data from an equivalent device can support your clinical evaluation, but the MDR sets a higher bar than the Directives did. The three characteristics, data access, and documentation.
One email when an area publishes, in the language you choose. Nothing else.
